HomepageEarnings Events Newsdesk 1 hour ago Repligen Corp (RGEN) Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network Repligen Corp (NASDAQ: RGEN) FY 2026 Other Release Merck & Co., Inc. (MRK) European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season » « Advanced Micro Devices Inc (AMD) Myseum.AI Accepted into Advanced Micro Devices AI Developer Program Newsdesk:
